These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8226750)

  • 1. Determination of the side chain pKa values of the lysine residues in calmodulin.
    Zhang M; Vogel HJ
    J Biol Chem; 1993 Oct; 268(30):22420-8. PubMed ID: 8226750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of trimethyllysine 115 in calmodulin by 14N and 13C NMR spectroscopy.
    Zhang M; Huque E; Vogel HJ
    J Biol Chem; 1994 Feb; 269(7):5099-105. PubMed ID: 8106489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive methylation and pKa determination of the lysine side chains in calbindin D9k.
    Zhang M; Thulin E; Vogel HJ
    J Protein Chem; 1994 Aug; 13(6):527-35. PubMed ID: 7832981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional NMR studies of selenomethionyl calmodulin.
    Zhang M; Vogel HJ
    J Mol Biol; 1994 Jun; 239(4):545-54. PubMed ID: 8006966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Phe-92 in the Ca(2+)-induced conformational transition in the C-terminal domain of calmodulin.
    Meyer DF; Mabuchi Y; Grabarek Z
    J Biol Chem; 1996 May; 271(19):11284-90. PubMed ID: 8626680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of the interactions between calmodulin and skeletal muscle myosin light chain kinase: effect of peptide (576-594)G binding on the Ca2+-binding domains.
    Seeholzer SH; Wand AJ
    Biochemistry; 1989 May; 28(9):4011-20. PubMed ID: 2752005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin.
    Findlay WA; Gradwell MJ; Bayley PM
    Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium binding and conformational properties of calmodulin complexed with peptides derived from myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP).
    Porumb T; Crivici A; Blackshear PJ; Ikura M
    Eur Biophys J; 1997; 25(4):239-47. PubMed ID: 9112755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of a calmodulin-target peptide complex by multidimensional NMR.
    Ikura M; Clore GM; Gronenborn AM; Zhu G; Klee CB; Bax A
    Science; 1992 May; 256(5057):632-8. PubMed ID: 1585175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon-13 NMR studies of the lysine side chains of calmodulin and its proteolytic fragments.
    Huque ME; Vogel HJ
    J Protein Chem; 1993 Dec; 12(6):695-707. PubMed ID: 8136020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the high affinity and low sequence specificity of calmodulin binding to its targets.
    Afshar M; Caves LS; Guimard L; Hubbard RE; Calas B; Grassy G; Haiech J
    J Mol Biol; 1994 Dec; 244(5):554-71. PubMed ID: 7990140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of smooth muscle myosin light chain kinase by calmodulin. Role of LYS(30) and GLY(40).
    Van Lierop JE; Wilson DP; Davis JP; Tikunova S; Sutherland C; Walsh MP; Johnson JD
    J Biol Chem; 2002 Feb; 277(8):6550-8. PubMed ID: 11748245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin binding to myosin light chain kinase begins at substoichiometric Ca2+ concentrations: a small-angle scattering study of binding and conformational transitions.
    Krueger JK; Bishop NA; Blumenthal DK; Zhi G; Beckingham K; Stull JT; Trewhella J
    Biochemistry; 1998 Dec; 37(51):17810-7. PubMed ID: 9922147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of calmodulin with its binding domain of rat cerebellar nitric oxide synthase. A multinuclear NMR study.
    Zhang M; Yuan T; Aramini JM; Vogel HJ
    J Biol Chem; 1995 Sep; 270(36):20901-7. PubMed ID: 7545663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR studies of the methionine methyl groups in calmodulin.
    Siivari K; Zhang M; Palmer AG; Vogel HJ
    FEBS Lett; 1995 Jun; 366(2-3):104-8. PubMed ID: 7789524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
    Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
    J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of amino acids essential for calmodulin binding and activation of smooth muscle myosin light chain kinase.
    Bagchi IC; Huang QH; Means AR
    J Biol Chem; 1992 Feb; 267(5):3024-9. PubMed ID: 1737757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable conformation and dynamics of calmodulin complexed with peptides derived from the autoinhibitory domains of target proteins.
    Yao Y; Squier TC
    Biochemistry; 1996 May; 35(21):6815-27. PubMed ID: 8639633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide analog of the calmodulin-binding domain of myosin light chain kinase adopts an alpha-helical structure in aqueous trifluoroethanol.
    Zhang M; Yuan T; Vogel HJ
    Protein Sci; 1993 Nov; 2(11):1931-7. PubMed ID: 8268802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.